These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 27751554)

  • 1. Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial.
    Hanley DF; Thompson RE; Muschelli J; Rosenblum M; McBee N; Lane K; Bistran-Hall AJ; Mayo SW; Keyl P; Gandhi D; Morgan TC; Ullman N; Mould WA; Carhuapoma JR; Kase C; Ziai W; Thompson CB; Yenokyan G; Huang E; Broaddus WC; Graham RS; Aldrich EF; Dodd R; Wijman C; Caron JL; Huang J; Camarata P; Mendelow AD; Gregson B; Janis S; Vespa P; Martin N; Awad I; Zuccarello M;
    Lancet Neurol; 2016 Nov; 15(12):1228-1237. PubMed ID: 27751554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial.
    Hanley DF; Thompson RE; Rosenblum M; Yenokyan G; Lane K; McBee N; Mayo SW; Bistran-Hall AJ; Gandhi D; Mould WA; Ullman N; Ali H; Carhuapoma JR; Kase CS; Lees KR; Dawson J; Wilson A; Betz JF; Sugar EA; Hao Y; Avadhani R; Caron JL; Harrigan MR; Carlson AP; Bulters D; LeDoux D; Huang J; Cobb C; Gupta G; Kitagawa R; Chicoine MR; Patel H; Dodd R; Camarata PJ; Wolfe S; Stadnik A; Money PL; Mitchell P; Sarabia R; Harnof S; Barzo P; Unterberg A; Teitelbaum JS; Wang W; Anderson CS; Mendelow AD; Gregson B; Janis S; Vespa P; Ziai W; Zuccarello M; Awad IA;
    Lancet; 2019 Mar; 393(10175):1021-1032. PubMed ID: 30739747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial.
    Bracard S; Ducrocq X; Mas JL; Soudant M; Oppenheim C; Moulin T; Guillemin F;
    Lancet Neurol; 2016 Oct; 15(11):1138-47. PubMed ID: 27567239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does stereotactic thrombolysis with alteplase for intracerebral haemorrhage alter intraventricular haematoma volume? A secondary analysis of the MISTIE-III trial.
    Sun P; Badihian S; Avadhani R; Walborn N; Yarava A; Alimoradi D; Awad I; Hanley D; Murthy S; Ziai W
    J Neurol Neurosurg Psychiatry; 2024 Sep; 95(10):892-898. PubMed ID: 38670789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary findings of the minimally-invasive surgery plus rtPA for intracerebral hemorrhage evacuation (MISTIE) clinical trial.
    Morgan T; Zuccarello M; Narayan R; Keyl P; Lane K; Hanley D
    Acta Neurochir Suppl; 2008; 105():147-51. PubMed ID: 19066101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized 500-subject open-label phase 3 clinical trial of minimally invasive surgery plus alteplase in intracerebral hemorrhage evacuation (MISTIE III).
    Ziai WC; McBee N; Lane K; Lees KR; Dawson J; Vespa P; Thompson RE; Mendelow AD; Kase CS; Carhuapoma JR; Thompson CB; Mayo SW; Reilly P; Janis S; Anderson CS; Harrigan MR; Camarata PJ; Caron JL; Zuccarello M; Awad IA; Hanley DF;
    Int J Stroke; 2019 Jul; 14(5):548-554. PubMed ID: 30943878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4·5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial.
    Gusev EI; Martynov MY; Nikonov AA; Shamalov NA; Semenov MP; Gerasimets EA; Yarovaya EB; Semenov AM; Archakov AI; Markin SS;
    Lancet Neurol; 2021 Sep; 20(9):721-728. PubMed ID: 34418399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study.
    Huang X; Cheripelli BK; Lloyd SM; Kalladka D; Moreton FC; Siddiqui A; Ford I; Muir KW
    Lancet Neurol; 2015 Apr; 14(4):368-76. PubMed ID: 25726502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical Trial.
    Fam MD; Hanley D; Stadnik A; Zeineddine HA; Girard R; Jesselson M; Cao Y; Money L; McBee N; Bistran-Hall AJ; Mould WA; Lane K; Camarata PJ; Zuccarello M; Awad IA
    Neurosurgery; 2017 Nov; 81(5):860-866. PubMed ID: 28402516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral small vessel disease modifies outcomes after minimally invasive surgery for intracerebral haemorrhage.
    Li Y; Cho SM; Avadhani R; Ali H; Hao Y; Murthy SB; Goldstein JN; Xia F; Hu X; Ullman NL; Awad I; Hanley D; Ziai WC
    Stroke Vasc Neurol; 2024 Aug; 9(4):446-456. PubMed ID: 37949482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial.
    Hanley DF; Lane K; McBee N; Ziai W; Tuhrim S; Lees KR; Dawson J; Gandhi D; Ullman N; Mould WA; Mayo SW; Mendelow AD; Gregson B; Butcher K; Vespa P; Wright DW; Kase CS; Carhuapoma JR; Keyl PM; Diener-West M; Muschelli J; Betz JF; Thompson CB; Sugar EA; Yenokyan G; Janis S; John S; Harnof S; Lopez GA; Aldrich EF; Harrigan MR; Ansari S; Jallo J; Caron JL; LeDoux D; Adeoye O; Zuccarello M; Adams HP; Rosenblum M; Thompson RE; Awad IA;
    Lancet; 2017 Feb; 389(10069):603-611. PubMed ID: 28081952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study).
    Robinson TG; Wang X; Arima H; Bath PM; Billot L; Broderick JP; Demchuk AM; Donnan GA; Kim JS; Lavados PM; Lee TH; Lindley RI; Martins SCO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Nguyen TH; Wang JG; Woodward M; Chalmers J; Anderson CS;
    Stroke; 2017 Jul; 48(7):1877-1883. PubMed ID: 28619989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis.
    Whiteley WN; Emberson J; Lees KR; Blackwell L; Albers G; Bluhmki E; Brott T; Cohen G; Davis S; Donnan G; Grotta J; Howard G; Kaste M; Koga M; von Kummer R; Lansberg MG; Lindley RI; Lyden P; Olivot JM; Parsons M; Toni D; Toyoda K; Wahlgren N; Wardlaw J; Del Zoppo GJ; Sandercock P; Hacke W; Baigent C;
    Lancet Neurol; 2016 Aug; 15(9):925-933. PubMed ID: 27289487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Mechanical Thrombectomy Without vs With Intravenous Thrombolysis on Functional Outcome Among Patients With Acute Ischemic Stroke: The SKIP Randomized Clinical Trial.
    Suzuki K; Matsumaru Y; Takeuchi M; Morimoto M; Kanazawa R; Takayama Y; Kamiya Y; Shigeta K; Okubo S; Hayakawa M; Ishii N; Koguchi Y; Takigawa T; Inoue M; Naito H; Ota T; Hirano T; Kato N; Ueda T; Iguchi Y; Akaji K; Tsuruta W; Miki K; Fujimoto S; Higashida T; Iwasaki M; Aoki J; Nishiyama Y; Otsuka T; Kimura K;
    JAMA; 2021 Jan; 325(3):244-253. PubMed ID: 33464334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Endovascular Treatment Alone vs Intravenous Alteplase Plus Endovascular Treatment on Functional Independence in Patients With Acute Ischemic Stroke: The DEVT Randomized Clinical Trial.
    Zi W; Qiu Z; Li F; Sang H; Wu D; Luo W; Liu S; Yuan J; Song J; Shi Z; Huang W; Zhang M; Liu W; Guo Z; Qiu T; Shi Q; Zhou P; Wang L; Fu X; Liu S; Yang S; Zhang S; Zhou Z; Huang X; Wang Y; Luo J; Bai Y; Zhang M; Wu Y; Zeng G; Wan Y; Wen C; Wen H; Ling W; Chen Z; Peng M; Ai Z; Guo F; Li H; Guo J; Guan H; Wang Z; Liu Y; Pu J; Wang Z; Liu H; Chen L; Huang J; Yang G; Gong Z; Shuai J; Nogueira RG; Yang Q;
    JAMA; 2021 Jan; 325(3):234-243. PubMed ID: 33464335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial.
    Logallo N; Novotny V; Assmus J; Kvistad CE; Alteheld L; Rønning OM; Thommessen B; Amthor KF; Ihle-Hansen H; Kurz M; Tobro H; Kaur K; Stankiewicz M; Carlsson M; Morsund Å; Idicula T; Aamodt AH; Lund C; Næss H; Waje-Andreassen U; Thomassen L
    Lancet Neurol; 2017 Oct; 16(10):781-788. PubMed ID: 28780236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) Procedure.
    Awad IA; Polster SP; Carrión-Penagos J; Thompson RE; Cao Y; Stadnik A; Money PL; Fam MD; Koskimäki J; Girard R; Lane K; McBee N; Ziai W; Hao Y; Dodd R; Carlson AP; Camarata PJ; Caron JL; Harrigan MR; Gregson BA; Mendelow AD; Zuccarello M; Hanley DF;
    Neurosurgery; 2019 Jun; 84(6):1157-1168. PubMed ID: 30891610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trial.
    Bivard A; Zhao H; Churilov L; Campbell BCV; Coote S; Yassi N; Yan B; Valente M; Sharobeam A; Balabanski AH; Dos Santos A; Ng JL; Yogendrakumar V; Ng F; Langenberg F; Easton D; Warwick A; Mackey E; MacDonald A; Sharma G; Stephenson M; Smith K; Anderson D; Choi P; Thijs V; Ma H; Cloud GC; Wijeratne T; Olenko L; Italiano D; Davis SM; Donnan GA; Parsons MW;
    Lancet Neurol; 2022 Jun; 21(6):520-527. PubMed ID: 35525251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke.
    Anderson CS; Robinson T; Lindley RI; Arima H; Lavados PM; Lee TH; Broderick JP; Chen X; Chen G; Sharma VK; Kim JS; Thang NH; Cao Y; Parsons MW; Levi C; Huang Y; Olavarría VV; Demchuk AM; Bath PM; Donnan GA; Martins S; Pontes-Neto OM; Silva F; Ricci S; Roffe C; Pandian J; Billot L; Woodward M; Li Q; Wang X; Wang J; Chalmers J;
    N Engl J Med; 2016 Jun; 374(24):2313-23. PubMed ID: 27161018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials.
    Emberson J; Lees KR; Lyden P; Blackwell L; Albers G; Bluhmki E; Brott T; Cohen G; Davis S; Donnan G; Grotta J; Howard G; Kaste M; Koga M; von Kummer R; Lansberg M; Lindley RI; Murray G; Olivot JM; Parsons M; Tilley B; Toni D; Toyoda K; Wahlgren N; Wardlaw J; Whiteley W; del Zoppo GJ; Baigent C; Sandercock P; Hacke W;
    Lancet; 2014 Nov; 384(9958):1929-35. PubMed ID: 25106063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.